Green monkey disease is a viral infection that was first identified in the 1950s among captive monkeys in Africa. The spelling of this disease is phonetically represented as /ɡriːn ˈmʌŋki dɪˌziːz/. The /ɡ/ represents the hard "g" sound, followed by a long "ee" sound represented by /riːn/. The word "monkey" is represented by /ˈmʌŋki/ with a short "u" sound followed by a hard "k" sound. The second part of the word, "disease", is represented by /dɪˌziːz/, with a short "i" sound and a "z" sound at the end.
"Green monkey disease" is a medical condition that primarily affects non-human primates, specifically the green monkey (Chlorocebus sabaeus) species. It is caused by a type of RNA virus known as the simian immunodeficiency virus (SIV). Green monkey disease is considered a zoonotic disease, meaning it can be transmitted from animals to humans under certain circumstances.
In non-human primates, green monkey disease is typically characterized by a chronic and latent infection, meaning the virus persists in the body for extended periods without causing obvious symptoms. However, in humans, the virus can lead to a severe and rapidly progressing illness known as simian immunodeficiency virus encephalopathy.
Symptoms of green monkey disease in humans can vary but often include fever, fatigue, muscle aches, headache, and nodes in lymphoid tissues. As the disease progresses, it may lead to neurological complications such as impaired motor skills, cognitive dysfunction, and paralysis.
To date, cases of green monkey disease in humans have been relatively rare and mainly limited to individuals working closely with infected non-human primates in laboratory or research settings. The transmission of the virus is primarily through contact with the animal's bodily fluids or tissue, such as blood, saliva, or through bites or scratches.
Due to the potential severity of symptoms and the lack of specific treatment options, prevention efforts have mainly focused on strict safety protocols when handling non-human primates, as well as the development of potential vaccines to protect individuals at high risk of exposure.